Early data suggest Sanofi, Regeneron drug may halve heart risk

* Good news for new PCSK9 drug class but needs confirmation
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.